- Bempedoic acid: Uses, Dosage, Side Effects, Warnings - Drugs. com
Bempedoic acid (brand name Nexletol) is an oral, non-statin, LDL cholesterol-lowering treatment that may be used in adults to: lower the risk of heart attack and heart procedures (for example stent placement or bypass surgery), in those unable to take recommended statin treatment (a cholesterol-lowering medicine), or are not taking a statin, who:
- Bempedoic acid (oral route) - Side effects dosage
Description Bempedoic acid is used together with diet and other cholesterol-lowering medicines to reduce bad cholesterol (LDL) in patients with primary hyperlipidemia (high blood cholesterol), including heterozygous familial hypercholesterolemia (HeFH) Bempedoic acid is also used to lower the risk of heart attack and heart procedures (eg, stent placement or bypass surgery) in patients who are
- Bempedoic Acid: Lipid Lowering for Cardiovascular Disease . . .
Bempedoic acid was associated with increases in uric acid levels and cholelithiasis, but numerically fewer events of myalgia and new-onset diabetes These findings confirm that bempedoic acid is an effective approach to reduce cardiovascular outcomes in high-risk patients with statin intolerance who require further reduction in LDL-C
- Efficacy of Bempedoic Acid, Novel Treatment for Elevated LDL . . .
By Anthony Rice Bempedoic acid is a novel non-statin drug produced by Esperion Therapeutics to treat hypercholesterolemia, elevated levels of low-density lipoprotein (LDL) cholesterol in the blood 1 In the double-blind, placebo-controlled, phase 3 2022 CLEAR Outcomes trial conducted by Esperion, bempedoic acid treatment was associated with reductions in major adverse cardiovascular events
- Bempedoic Acid: Uses, Dosage, Side Effects, and Interactions
Learn about the indications, dosage, and potential side effects of bempedoic acid, a medication used in the treatment of hypercholesterolemia Understand its mechanism of action and important considerations for use
- Cleveland Clinic-Led Trial Shows That The First Drug Designed . . .
Bempedoic acid is approved by the U S Food and Drug Administration as an additional treatment to help lower cholesterol in patients with certain conditions who have high cholesterol despite maximally tolerated statin therapy The trial, called CLEAR Outcomes, is the first to explore whether bempedoic acid could reduce cardiovascular outcomes
- Is This New Medication Another Solution For High Cholesterol?
Bempedoic acid lowered cholesterol in people who are at high risk of heart disease by 21% Last month, the Journal of the American Medical Association (JAMA) published a study that explored the use of bempedoic acid ― a fairly new medication that was approved by the FDA in 2020 ― as a cholesterol-lowering drug
- Bempedoic Acid and Cardiovascular Outcomes in Statin . . .
In several studies, bempedoic acid reduced the level of LDL cholesterol by 17 to 28%, a finding that, in 2020, prompted its approval by the Food and Drug Administration and the European Medicines
|